SAN DIEGO, Sept. 22, 2008 (GLOBE NEWSWIRE) -- Asphelia Pharmaceuticals, a privately held, clinical-stage company focused on the development of novel therapeutics for the treatment of immunological disorders, will be presenting at a number of international conferences this Fall, including:
